Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guizhou Miao Ridge Miao Medicine Research Institute is a specialized research and development organization based in Guiyang, China, focused on the advancement of traditional Miao ethnic medicine. The institute serves as the primary R&D hub for the Miaoling Pharmaceutical group, utilizing the unique botanical resources of the Guizhou plateau to develop modern pharmaceutical products. Its research portfolio primarily targets conditions in dermatology, otorhinolaryngology, and pediatrics, with a focus on inflammatory and respiratory ailments. The institute is credited with the scientific formulation of several commercially successful ethnic medicines, such as Miaoling Bi-Tong-Ning for rhinitis and Miaoling Jie-Du-Zhi-Yang for skin disorders. By integrating traditional herbal knowledge with modern clinical standards, the institute plays a pivotal role in the standardization and industrialization of Miao medicine. It maintains strong ties with regional academic institutions to further the pharmacological understanding of ethnic treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guizhou Miao Ridge Miao Medicine Research Institute.